Shingrix Effectiveness in Preventing Shingles in Seniors
A real-world analysis reveals that Shingrix is highly effective in preventing shingles in adults over 65, including those with compromised immune systems.
Shingles is a viral infection caused by the reactivation of the varicella-zoster virus (VZV), which also causes chickenpox. It commonly affects adults over 50, presenting as a rash with painful blisters, and can lead to post-herpetic neuralgia (PHN), a long-lasting nerve pain.
- Two doses of Shingrix provide better protection than one.
- Shingrix is effective in preventing shingles in immunocompromised adults.
- The vaccine is manufactured by GSK and is a recombinant zoster vaccine (RZV).
Shingles can cause a long-lasting nerve pain that can last weeks or months, affecting between 5% and 30% of patients.
Author's summary: Shingrix is highly effective in preventing shingles.
More News
- Sheinbaum unveils flood website and says Fitch is 'wrong' about her latest reform: Thursday's mañanera recapped
- Frost and Freeze alerts spread across all of NCWV
- Mamdani and Cuomo Get Personal in NYC Mayoral Debate: Updates
- Why I still love newspapers
- PVI Insurance sees 9-month profit before tax more than doubling
- MotoGP™ stars warm up for Malaysia with some Table Tennis!
- FCA’s targeted support proposals are limited but still worthwhile
- Blizzard Watch Weekly: Everything is coming up Midnight
- Opinion: Can A 690cc Flat-Tracker Replace 250cc Moto3 Singles?
- Celebrities spotted at MTRCB's 40th Anniversary celebration